Medicine
Oxaprozin 600 mg tablet
Oxaprozin 600 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F)…
Key facts
- Active ingredient (INN)
- Oxaprozin
- Brand
- Sold under the generic name
- Strength
- 600 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 180 tablets and 20 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaBryant Ranch PrepackAmneal Pharmaceuticals NYChartwell RXDirect_RxProficient RxSt. Mary's Medical Park Pharmacy
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F). Storage Keep bottles tightly closed.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M01AE12 Oxaprozin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 2001
- Identifiers
- RxCUI 312132DailyMed set ID dcb85e40-3427-4e56-910d-c1b07bb5c0fa, e881dca6-004e-1c3e-e053-2a95a90a02ab, e3fbea8c-bc0d-4dcd-a14e-a4575dceeea6 +5NDC 71335-0393, 60760-382, 82804-261 +5Application ANDA075855, ANDA075987, ANDA208633
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 55111-170-01 | Dr. Reddy's LaboratoriesIndia | 31 January 2001 |
| 500 tablet, film coated in 1 bottle | 55111-170-05 | Dr. Reddy's LaboratoriesIndia | 31 January 2001 |
| 100 tablet in 1 bottle | 69238-1120-1 | Amneal Pharmaceuticals NY | 4 May 2017 |
| 500 tablet in 1 bottle | 69238-1120-5 | Amneal Pharmaceuticals NY | 4 May 2017 |
| 180 tablet in 1 bottle | 62135-176-18 | Chartwell RX | 22 August 2022 |
| 60 tablet in 1 bottle | 62135-176-60 | Chartwell RX | 22 August 2022 |
| 30 tablet, film coated in 1 bottle | 71335-0393-1 | Bryant Ranch Prepack | 12 September 2007 |
| 20 tablet, film coated in 1 bottle | 71335-0393-2 | Bryant Ranch Prepack | 12 September 2007 |
| 14 tablet, film coated in 1 bottle | 71335-0393-3 | Bryant Ranch Prepack | 12 September 2007 |
| 60 tablet, film coated in 1 bottle | 71335-0393-4 | Bryant Ranch Prepack | 12 September 2007 |
| 90 tablet, film coated in 1 bottle | 71335-0393-5 | Bryant Ranch Prepack | 12 September 2007 |
| 6 tablet, film coated in 1 bottle | 71335-0393-6 | Bryant Ranch Prepack | 12 September 2007 |
| 120 tablet, film coated in 1 bottle | 71335-0393-7 | Bryant Ranch Prepack | 12 September 2007 |
| 30 tablet in 1 bottle | 71335-0617-1 | Bryant Ranch Prepack | 27 December 2021 |
| 20 tablet in 1 bottle | 71335-0617-2 | Bryant Ranch Prepack | 27 December 2021 |
| 14 tablet in 1 bottle | 71335-0617-3 | Bryant Ranch Prepack | 27 December 2021 |
| 60 tablet in 1 bottle | 71335-0617-4 | Bryant Ranch Prepack | 14 February 2018 |
| 90 tablet in 1 bottle | 71335-0617-5 | Bryant Ranch Prepack | 5 April 2018 |
| 6 tablet in 1 bottle | 71335-0617-6 | Bryant Ranch Prepack | 27 December 2021 |
| 120 tablet in 1 bottle | 71335-0617-7 | Bryant Ranch Prepack | 27 December 2021 |
| 60 tablet, film coated in 1 bottle | 72189-595-60 | Direct_Rx | 2 December 2024 |
| 60 tablet, film coated in 1 bottle | 82804-261-60 | Proficient Rx | 12 December 2025 |
| 14 tablet, film coated in 1 bottle, plastic | 60760-382-14 | ST Mary's Medical Park Pharmacy | 15 August 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 October 1992 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oxaprozin
Clinical summary
Oxaprozin is a nonsteroidal anti-inflammatory drug. It is available as tablets and capsules for oral use. MedsAcross supplies Oxaprozin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxaprozinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Oxaprozin prescribing information (SOLA Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Oxaprozin 600 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.